People · Operator

David L. Kessenich

Named in public records as an officer, director or promoter · active 2012–2017 · Hospitals and Physicians, Other, Other Health Care

3
Companies
3
Filings
$213.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Premier Imaging Holdings, LLCHospitals and PhysiciansSeries C$86.7M$1.8B2016
Biocare Holdings, LLCOtherSeries C$85.0M$1.5B2017
PhyMed Holdings, LLCOther Health CareSeries C$42.0M$960.2M2012
Operator network

David L. Kessenich at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Nathan L. Raulin · 2 companies · 1 sharedNathan L. RaulinDouglas Reader · 1 companies · 1 sharedDouglas ReaderMark Alfonso · 1 companies · 1 sharedMark AlfonsoPatrick L. O'Keefe · 1 companies · 1 sharedPatrick L. O'KeefeJustin Unertl · 2 companies · 1 sharedJustin UnertlRyan Glaws · 2 companies · 1 sharedRyan GlawsRoy L. Yih · 1 companies · 1 sharedRoy L. YihRobert A. Martin · 4 companies · 1 sharedRobert A. MartinDavid Whitten · 3 companies · 1 sharedDavid WhittenJustin L. Unertl · 1 companies · 1 sharedJustin L. UnertlMatthew A. Hicks · 1 companies · 1 sharedMatthew A. HicksPremier Imaging Holdings, LLC · $86.7M raisedPremier Imaging Holdi…Biocare Holdings, LLC · $85.0M raisedBiocare Holdings, LLCPhyMed Holdings, LLC · $42.0M raisedPhyMed Holdings, LLCDavid L. KessenichDK
David L. Kessenich Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David L. Kessenich on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Robert A. Martin14
David Whitten13
Nathan L. Raulin12
Justin Unertl12
Ryan Glaws12
Roy L. Yih11
Mark Alfonso11
Patrick L. O'Keefe11
Douglas Reader11
Matthew A. Hicks11
Justin L. Unertl11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.